<p>Bexsero is a vaccine used to protect individuals from the age of two months against invasive meningococcal disease caused by one group of the bacterium <em>Neisseria meningitidis (group B). </em>Invasive disease occurs when the bacteria spread through the body causing serious infections such as meningitis (infection of the membranes that surround the brain and spine) and septicaemia (blood infection).</p><p>Bexsero contains parts of the bacteria <em>N. meningitidis</em> group B.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Active immunisation against invasive disease caused by <em>Neisseria meningitidis</em> serogroup-B strains.</p></div>
Therapeutic Area (MeSH)
ATC Code
J07AH09
ATC Item
N/A
Pharmacotherapeutic Group
Meningococcal vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254) | N/A | outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254) |
| recombinant Neisseria meningitidis group B fHbp fusion protein | N/A | recombinant Neisseria meningitidis group B fHbp fusion protein |
| recombinant Neisseria meningitidis group B NadA protein | N/A | recombinant Neisseria meningitidis group B NadA protein |
| recombinant Neisseria meningitidis group B NHBA fusion protein | N/A | recombinant Neisseria meningitidis group B NHBA fusion protein |
EMA Name
Bexsero
Medicine Name
Bexsero
Aliases
N/ANo risk management plan link.
